A trial of 108 adults found semaglutide (GLP-1) injections reduced heavy drinking days by 12 days in 30 days, 50% better than placebo.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity, finds small trial
108 Adults Trial participants
12 Days per 30 days Heavy drinking reduction (semaglutide)
8 Days per 30 days Heavy drinking reduction (placebo)
The Lancet Publication venue
50% improvement over placebo
12 Days In 30 Days heavy drinking days reduced